Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

about

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

Item

http://www.wikidata.org/entity/Q58781967

description

article

@en

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Safety and effectiveness of es ...... ts with depression and anxiety

@en

Safety and effectiveness of es ...... ts with depression and anxiety

@nl

type

Item

label

Safety and effectiveness of es ...... ts with depression and anxiety

@en

Safety and effectiveness of es ...... ts with depression and anxiety

@nl

prefLabel

Safety and effectiveness of es ...... ts with depression and anxiety

@en

Safety and effectiveness of es ...... ts with depression and anxiety

@nl

P1476

Safety and effectiveness of es ...... ts with depression and anxiety

@en

P2093

Cuili Hu

http://www.w3.org/2001/XMLSchema#string

Gang Wang

http://www.w3.org/2001/XMLSchema#string

Jian Xie

http://www.w3.org/2001/XMLSchema#string

Jianmin Zhuo

http://www.w3.org/2001/XMLSchema#string

Jinan Wang

http://www.w3.org/2001/XMLSchema#string

Jun Ma

http://www.w3.org/2001/XMLSchema#string

Ludong Bai

http://www.w3.org/2001/XMLSchema#string

QiZhong Yi

http://www.w3.org/2001/XMLSchema#string

Xiufeng Xu

http://www.w3.org/2001/XMLSchema#string

Xiumin You

http://www.w3.org/2001/XMLSchema#string

P2860

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

A new depression scale designed to be sensitive to change

Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale.

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Depression and disability: comparisons with common physical conditions in the Ibadan study of aging.

Patient-reported outcomes before and after treatment of major depressive disorder.

Comorbid anxiety as a suicide risk factor among depressed veterans.

Comorbidity of depressive and anxiety disorders: challenges in diagnosis and assessment

P304

2087-2097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S164673

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30147321

http://www.w3.org/2001/XMLSchema#string

P932

6097511

http://www.w3.org/2001/XMLSchema#string